Latest news
News
Landmark Clinical Trials on MND Begin in Glasgow
A groundbreaking clinical trial for motor neurone disease (MND) begins today at the Queen Elizabeth …
News
Slow release opioid substitute gives Glasgow patients new lease of life
A slow release opioid substitute is helping opioid dependent patients get their lives back on track …
News
COVID survivors enrolled in unique rehabilitation programme
A specially designed rehabilitation initiative for Intensive Care Unit (ICU) patients is helping spe…
Additional news resources
Contacts for media and journalist enquiries only!
News on social media
Facebook Posts
Here’s why attending your smear test appointment is so important. Have the conversation about cervical screening today and encourage your friends to book their appointment if they’re due. ![]()
![]()
Thanks to friends and colleagues Corinne and Ashley for sharing their story.![]()
![]()
For more information on Cervical Screening visit: nhsggc.scot/nofear![]()
![]()
#DontFearTheSmear
We’re playing a leading role in a new study looking at how AI could help diagnose lung cancer earlier and keep patients safer.![]()
![]()
Working with partners across the UK, the SWIFT-Lung study is testing new digital tools to help us spot and assess lung nodules more quickly, so people get the right care at the right time.![]()
![]()
A key part of this is a system that automatically flags patients who may need follow-up, helping make sure no one is missed and reducing delays in diagnosis.![]()
![]()
Lung cancer is still the most common cause of cancer-related death in the UK, so earlier diagnosis can make a real difference to outcomes.![]()
![]()
By supporting our clinical teams with better information and prioritisation, this work aims to improve patient safety, reduce waiting times and make the diagnostic process less stressful for patients.![]()
![]()
Read more: www.nhsggc.scot/nhs-greater-glasgow-and-clyde-leads-new-study-using-ai-to-improve-lung-cancer-dia…
Was this helpful?
Thanks for your feedback!